Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval.

MLA

Hughes, Jim H., et al. “Concentration-QTc and Cardiac Safety Analysis of Single and Multiple Zavegepant Nasal Spray Doses in Healthy Participants to Support Approval.” CPT: Pharmacometrics & Systems Pharmacology, vol. 13, no. 6, June 2024, pp. 1044–54. EBSCOhost, https://doi.org/10.1002/psp4.13140.

APA

Hughes, J. H., Bertz, R., Bhardwaj, R., Donohue, M. K., Madonia, J., Anderson, M. S., Morris, B. A., Croop, R. S., & Liu, J. (2024). Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval. CPT: Pharmacometrics & Systems Pharmacology, 13(6), 1044–1054. https://doi.org/10.1002/psp4.13140

Chicago

Hughes, Jim H, Richard Bertz, Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Matt S Anderson, Beth A Morris, Robert S Croop, and Jing Liu. 2024. “Concentration-QTc and Cardiac Safety Analysis of Single and Multiple Zavegepant Nasal Spray Doses in Healthy Participants to Support Approval.” CPT: Pharmacometrics & Systems Pharmacology 13 (6): 1044–54. doi:10.1002/psp4.13140.